Cargando…
A Novel Blood-Brain Barrier-Permeable Chemotherapeutic Agent for the Treatment of Glioblastoma
Introduction The standard treatment for glioblastoma (GBM) patients is surgical tumor resection, followed by radiation and chemotherapy with temozolomide (TMZ). Unfortunately, 60% of newly diagnosed GBM patients express high levels of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGM...
Autores principales: | Ozawa, Tomoko, Rodriguez, Mirna, Zhao, Guisheng, Yao, Tsun Wen, Fischer, Wolf-Nicolas, Jandeleit, Bernd, Koller, Kerry, Nicolaides, Theodore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482806/ https://www.ncbi.nlm.nih.gov/pubmed/34646647 http://dx.doi.org/10.7759/cureus.17595 |
Ejemplares similares
-
LPTO-06. A NOVEL BRAIN-PERMEANT CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS
por: Deng, Jiaojiao, et al.
Publicado: (2019) -
Carboplatin Plus Vincristine as an Alternative Chemotherapeutic Scheme in Patients With Glioblastoma
por: Sangrador-Deitos, Marcos V, et al.
Publicado: (2022) -
A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021) -
Crossed Aphasia as a Manifestation of Glioblastoma
por: Zammar, Samer G, et al.
Publicado: (2018) -
Rapidly Fatal Radiation-induced Glioblastoma
por: Ng, Ivy, et al.
Publicado: (2017)